miR-155 and miR-146b negatively regulates IL6 in Helicobacter pylori (cagA+) infected gastroduodenal ulcer

S F Cheng1, L Li, L M Wang

  • 1Emergency Department, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China. chengsanfang@sina.com.

Abstract

Insights

MicroRNAs miR-155 and miR-146b are upregulated in Helicobacter pylori (H. pylori) infections, reducing IL6 overexpression and potentially contributing to gastroduodenal ulcers. This finding offers new insights into H. pylori pathogenesis.

Area of Science:

  • Molecular biology
  • Gastroenterology
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) infection is a primary cause of gastroduodenal ulcers, but underlying molecular mechanisms remain unclear.
  • MicroRNAs (miRNAs) are key post-transcriptional regulators involved in various diseases, yet their role in H. pylori-induced ulcers is understudied.

Purpose of the Study:

  • To investigate the roles of miRNAs in the pathogenesis of H. pylori-infected gastroduodenal ulcers.
  • To identify specific miRNAs and their target genes involved in the development of H. pylori-related gastroduodenal pathology.

Main Methods:

  • Comparative analysis of miRNA and mRNA profiles in normal, H. pylori-infected, and ulcer biopsy samples.
  • Validation of differential miRNA and target gene expression using immunohistochemistry and RT-PCR.
  • In vitro experiments involving miRNA mimic transfection in H. pylori-infected gastric epithelial cells, followed by RT-PCR and Western blotting.

Main Results:

  • miR-155 and miR-146b were found to be upregulated in H. pylori-positive gastroduodenal ulcers.
  • Interleukin-6 (IL6) was identified as a target gene, showing upregulation in infected tissues.
  • H. pylori infection induced IL6 overexpression, which was subsequently attenuated by the negative regulation of miR-155 and miR-146b.

Conclusions:

  • Upregulation of miR-155 and miR-146b mitigates H. pylori-induced IL6 overexpression.
  • This miRNA-mediated regulation may impair bacterial clearance, contributing to the development of gastroduodenal ulcers.
  • The findings highlight a novel miRNA-based mechanism in H. pylori pathogenesis.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.4K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
36
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.3K
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
60